ctrl K

Caladrius Biosciences Inc... (CLBS)

NASDAQ: CLBS · Real-Time Price · USD

0.43

-0.08 (-16.05%)

At close: Sep 15, 2022, 4:00 AM

Caladrius Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
PE Ratio	-0.47	-2.71	-1.34	-2.13	-1.95	-0.56
PEG Ratio	-0.00	0.04	-0.11	0.30	0.03	0.01
PS Ratio	n/a	n/a	n/a	n/a	n/a	0.53
PB Ratio	0.14	0.68	1.24	0.91	0.62	3.79
P/FCF Ratio	-0.58	-2.5	-1.37	-1.71	-1.5	-0.7
P/OCF Ratio	-0.58	-2.5	-1.37	-1.73	-1.51	-0.78
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	-0.67
Debt / Equity Ratio	n/a	0.01	0.02	n/a	0.00	1.39
Quick Ratio	21.00	10.08	4.35	7.85	6.56	1.26
Current Ratio	21.00	10.08	4.35	7.85	6.56	1.26
Asset Turnover	n/a	n/a	n/a	n/a	n/a	0.68
Interest Coverage	n/a	n/a	n/a	-3.23K	31.32	-16.5
Return on Equity	-0.3	-0.25	-0.93	-0.43	-0.32	-6.82
Return on Assets	-0.28	-0.23	-0.71	-0.36	-0.26	-0.64
Return on Invested Capital	-0.3	-0.25	-0.91	-0.43	0.14	-2.64
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	0.12
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	-0.94
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	-0.94
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	-0.87
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	-0.79